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Sarcoidosis is a multisystem granulomatous disease of unknown origin. It typically involves the lungs and mediastinal lymph
nodes in a chronic fashion. However, acute syndrome has been reported possibly in response to systemic release of proin-
ﬂammatory cytokines. Acute pulmonary manifestations, especially acute respiratory failure or acute respiratory distress syn-
drome, remain extremely uncommon in individuals without a prior diagnosis. We present the case of a 41-year-old African
American female, who presented with ARDS. An extensive workup into the cause of her illness remained negative, and she
subsequently succumbed to her illness. A diagnosis of sarcoidosis was made upon autopsy, after exclusion of other granulomatous
illness. *e case highlights the need to consider this uncommon diagnosis in patients with unexplained ARDS to guide therapy.
1. Introduction
Sarcoidosis is a multisystem granulomatous disease of un-
known etiology. Frequently aﬀecting the mediastinal lymph
nodes and lungs, cutaneous, hepatic, and ocular manifes-
tations are also common. It can also involve the myocar-
dium, central nervous system, spleen, and upper respiratory
tract. Involvement is primarily in the form of nonnecrotizing
granuloma formation, in response to T-cell-mediated
delayed hypersensitivity reaction, recruiting macrophages
and release of inﬂammatory cytokines TNF-a and IL-2.
Pulmonary involvement is usually slow, leading to a
chronic interstitial lung disease with progressive dyspnea,
cough, and fatigue ailing aﬀected individuals. Acute pul-
monary presentations are uncommon and typically occur in
advanced sarcoidosis in response to infection, broncho-
spasm, or injury causing deterioration of the respiratory
status. Even less common is an acute initial presentation
with respiratory failure in a previously undiagnosed patient,
with only a handful of cases reported in the English liter-
ature. We describe one such case of a young woman with
acute respiratory distress syndrome and respiratory failure
diagnosed as sarcoidosis posthumously (Figures 1 and 2).
2. Case
A 41-year-old African American female presented to the
emergency department with a cough, dyspnea, fevers, chills,
night sweats, and fatigue.
She had never experienced pulmonary symptoms two
weeks before presentation when she developed a cough and
fever and was prescribed oral levoﬂoxacin for pneumonia by
her primary care physician. Completing a 7-day course of
antibiotics, with unabating symptoms and worsening
dyspnea, she presented to the emergency department for
further treatment.
*e examination was remarkable for tachypnea with a
respiratory rate of 30/min, hypoxemia with an oxygen sat-
uration of 87% in room air, and diﬀuse bilateral crackles,
without jugular venous distension, or lower extremity edema.
Blood test was signiﬁcant for white blood cell count of
30,000/µL, lactic acid of 5mEq/L, and a normalmetabolic panel.
Arterial blood gas revealed a pH of 7.17, PaCO2 of 50mmHg,
HCO3 of 19mmol/L, PaO2 of 65.3mmHg, and SaO2 of 87%.
A CT-PE of the chest showed bilateral extensive mul-
tifocal inﬁltrates with signiﬁcant hilar and mediastinal
lymphadenopathy and no evidence of pulmonary embolism.
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She was intubated for respiratory distress and admitted
to the medical intensive care unit, with a tentative diagnosis
of sepsis secondary to pneumonia, and started on broad-
spectrum antibiotics.
A parasite smear and initial blood cultures were negative.
Bronchoscopy done on the day of admission showed
mild diﬀuse erythema without hemorrhage. Given the pa-
tient’s repeated desaturation during the procedure, trans-
bronchial biopsies were not performed and the procedure
terminated early. Lavage was sent for cytology, bacterial,
mycobacterial, and fungal stain, and culture.
An echocardiogram showed a hyperdynamic left ven-
tricle with an estimated ejection fraction of 70% with severe
right ventricular dilatation and hypokinesis. Right ventric-
ular systolic pressure was estimated at 80mmHg with a
tricuspid annular plane systolic excursion (TAPSE) of 1.3.
She continued to worsen, with worsening hypoxia and
diﬃculty with mechanical ventilation, ultimately requiring
airway pressure release ventilation and inhaled epoproste-
nol. Bronchoalveolar lavage remained negative, for bacteria,
fungi, or Pneumocystis jirovecii sp.
Workup was expanded to include fungal blood cultures,
histoplasma and coccidioides serology, and viral respiratory
panel. Respiratory syncytial virus, adenovirus, inﬂuenza,
parainﬂuenza, human metapneumovirus, human immuno-
deﬁciency virus (HIV), Ebstein–Barr virus (EBV), and
(a) (b)
(c)
Figure 1: Histopathology. (a) Low-power view of lung parenchyma showing multiple giant cell formation and granuloma formation. (b)
Giant cell and granuloma formation in hepatic parenchyma. (c) High-power view of granulomas and giant cells in the lymph node.
(a) (b)
Figure 2: Radiographic appearance at presentation.
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cytomegalovirus (CMV) were negative. Leptospira and per-
tussis remained negative. Noninfectious workup along au-
toimmune lines including antinuclear antibody (ANA), anti-
neutrophilic cytoplasmic antibody (ANCA), rheumatoid
factor (RF), anti-cyclic citrullinated peptide (anti-CCP), and
anti-Smith, anti-SCL70, anti-myeloperoxidase (anti-MPO),
anti-ribonucleoprotein (anti-RNP), and anti-PR3 antibodies
all returned negative, with angiotensin-converting enzyme
(ACE) levels on the high end of normal.
She continued to worsen, requiring hemodynamic
support with norepinephrine, epinephrine, and vasopres-
sin, with worsening hepatic function and oliguric renal
failure.
On the third hospital day, she continued to be febrile.
Morning ABG showed a pH of 6.99, PaCO2 of 47.4mmHg,
HCO3 of 10mmol/L, PaO2 of 88.2mmHg, SO2 of 83.2%, and
lactic acid level of 9mEq/L; after prompt discussion with the
family, the decision was made to start the patient on con-
tinuous renal replacement therapy (CRRT) and consider
extracorporeal membrane oxygenation (ECMO) support.
However, the patient developed pulseless electrical ac-
tivity (PEA) arrest before CRRT could begin, with the
eventual demise of the patient.
An autopsy revealed noncaseating granulomata in hilar
and mediastinal lymph nodes and pulmonary, splenic, and
hepatic parenchyma. Gram, Ziehl–Neelsen, and special
stains were negative for bacterial, mycobacterial, fungal, or
parasitic organisms.
Acid-fast bacillary and fungal cultures remained nega-
tive. No crystals were seen on polarized microscopy.
3. Discussion
Overall, African Americans have a threefold age-adjusted
annual incidence of sarcoidosis when compared to Cauca-
sians [1].
*ere is no diagnostic laboratory or imaging study
available. A joint consensus statement recommends three
criteria for the diagnosis of sarcoidosis: (a) a compatible
clinical and radiologic presentation, (b) pathologic evidence of
noncaseating granulomas, and (c) exclusion of other diseases
with similar ﬁndings [2]. Clinical suspicion is critical for di-
agnosing sarcoidosis, a constellation of consistent symptoms,
and supporting imaging is of paramount importance.
Although the initial diagnosis is made on clinicor-
adiographic ﬁndings, a tissue biopsy is warranted to conﬁrm
the diagnosis. *e presence of noncaseating granulomas
demonstrated on microscopic evaluation is typical. How-
ever, other granulomatous disorders need to be excluded
before a determination can be made. *e diagnosis is made
even more diﬃcult when clinical suspicion is low, owing to
diﬀerent presentations like in our case.
Our patient met the Berlin criteria for ARDS at pre-
sentation. Owing to the lack of a satisfactory underlying
diagnosis, an extensive workup [3] was performed which
Table 1
Author Year Patient Symptoms
Duration
of
symptoms
Radiographic ﬁndings Biopsy Treatment andoutcome
Sahn et. al. [11] 1974 26,female
Dyspnea, productive
cough, and chest pain 1 month
Bilateral diﬀuse inﬁltrates
without adenopathy
Open lung
biopsy
Improvement with
prednisone
Suyama et. al.
[12] 1990
55,
male Dyspnea and fever 10 days
Diﬀuse small nodular
opacity, with bilateral
lymphadenopathy
Transbronchial
lung biopsy
Improvement with
prednisone
Sabbagh et al.
[9] 2002
50,
male
Dyspnea and
productive cough 3 weeks
Extensive bilateral
interstitial inﬁltrates
Transbronchial
lung biopsy
Improvement with
prednisone
Leiba et al. [13] 2004 41,female Dyspnea 1 week
Bilateral reticulonodular
opacities
Mediastinal
lymph node
biopsy
Improvement with
prednisone
Chirakalwasan
and Dallal [14] 2005
33,
male
Acute respiratory
distress syndrome 4 days
Bilateral pulmonary
inﬁltrates
Transbronchial
lung biopsy
Improvement with
methylprednisolone
Shibata et al.
[10] 2007
66,
male
Leg rash, fever, and
acute respiratory failure n/a
Bilateral ground glass
opacity Skin biopsy
Improvement with
steroids
Gupta et al. [7] 2011 40,male
Dyspnea, cough, fever,
malaise, and weight loss 3 weeks
Bilateral patchy ground
glass opacity with
interlobular thickening
and scattered nodules
Lung biopsy Improvement withmethylprednisolone
Gera et al. [6] 2014 30,male
Dyspnea, cough, and
fever 20 days
Bilateral
lymphadenopathy and
conﬂuent alveolar
opacities with air
bronchograms
Transbronchial
biopsy
Improvement with
prednisone
Arondi et al.
[5] 2016
20,
female
Dry cough, fatigue, and
fever 1 week
Bilateral
lymphadenopathy with
diﬀuse ground glass
opacities
Transbronchial
biopsy
Improvement with
methylprednisolone
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remained negative. She succumbed to her illness, primarily
from worsening ARDS and right heart failure. *e dem-
onstration of granulomata in the mediastinal nodes, pul-
monary parenchyma, and hepatic tissue suggested the
diagnosis posthumously, which was made after staining and
culture for microbial pathogens, includingmycobacteria and
fungi.
Sarcoidosis does not generally cause a fulminant pul-
monary syndrome, as in our patient. Only scattered case
reports exist of febrile illness attributed to sarcoidosis
outside of the well-described Heerfordt-Waldenstro¨m
syndrome, also referred to as sarcoid uveoparotid fever [4].
An acute manifestation of sarcoidosis most commonly
presents as Lo¨fgren’s syndrome, characterized by the classic
triad of hilar adenopathy, erythema nodosum, and arthritis.
Lung involvement is most common in sarcoidosis.
However, acute respiratory failure and acute respiratory
distress syndrome are incredibly rare initial presentations of
sarcoidosis, with a handful of reports in the literature [5–12].
Table 1 provides some details about reported cases.
Interestingly, acute febrile presentations appear to be
extremely rare. Suyuma et al. have previously described a
similar patient with high fevers and acute respiratory failure
diagnosed subsequently as pulmonary sarcoidosis [12].
Previously, authors have termed a rapidly manifesting
variant as alveolar sarcoidosis, owing to the acuity of onset
and radiologic pattern consistent with diﬀuse alveolar
inﬁltrates and presence of air bronchograms. In-
terestingly, most patients diagnosed with alveolar sar-
coidosis also did not present with respiratory failure. Two
such cases have been documented, by Sahn et al. [11] and
Gera et al. [6].
An acute inﬂammatory syndrome is poorly understood
and postulated in response to the systemic activation of
T-cell-mediated immune response and activation of the
interferon-gamma and interleukin-2 pathways which can
then lead to the development of ARDS [8].
Sarcoidosis is not a usual cause of ARDS and is seldom
cited as the underlying pathology in these patients; as our
case and other cases before illustrated, it is essential to
consider this in the diﬀerential for unexplained ARDS.
*is is the only reported case of ARDS from an acute
febrile presentation of sarcoidosis which was diagnosed
posthumously, highlighting the importance of considering it
in patients with ARDS from an unknown underlying disease
process.
4. Conclusion
Acute respiratory failure due to ARDS is an underrecognized
presentation of sarcoidosis and can be potentially fatal if not
treated promptly. Physicians need to be vigilant in con-
sidering sarcoidosis as a cause of ARDS after excluding
common etiologies.
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